Trial record 17 of 18 for: "Basal Ganglia Disease" | "Benserazide"
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
|ClinicalTrials.gov Identifier: NCT01646255|
Recruitment Status : Completed
First Posted : July 20, 2012
Results First Posted : January 22, 2016
Last Update Posted : April 4, 2018
UCB Trading (Shanghai) Co. Ltd.
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Double (Participant, Investigator); Primary Purpose: Treatment|
Idiopathic Parkinson's Disease
Drug: Placebo Patch
|Recruitment Details||This multicenter, randomized, double-blind, parallel-group, placebo-controlled study started recruiting in August 2012.|
|Pre-assignment Details||Participant Flow refers to the Safety Set (SS), consisting of all randomized subjects who received at least 1 dose of study medication.|